Association of silent infarcts in sickle cell anemia with decreased annexin A5 resistance

Kerry A. Morrone, Lydia H. Pecker, Jacob Rand, Jennifer Davila, Suzette Oyeku, Jane A. Little, Xue Xiaonan, Deepa Manwani

Research output: Contribution to journalArticle

Abstract

Background Sickle cell anemia (SCA) is characterized by abnormally shaped, adhesive RBCs that interact with white blood cells and the endothelium, leading to chronic hemolysis, vasculopathy and a prothrombotic state. About 10% of subjects with a thrombotic event in the general population will have an associated antiphospholipid (aPL) antibody. One proposed mechanism for the thrombophilic nature of aPL antibodies is the disruption of the potent anticoagulant annexin A5 or Annexin A5 resistance (A5R). We designed a pilot study assessing the presence of aPL antibodies and disruption of A5R in pediatric sickle cell subjects. Methods 39 subjects with SCA participated in this study. A5R, DRVVT, anti-β2GP1, anti-β2GP1, anti-phosphatidylserine and anti-cardiolipin antibody assays were performed. Results There was a high prevalence of abnormal A5R despite a low prevalence of antiphospholipid antibodies. Multivariate logistic regression analyses showed an association with silent infarcts (p = 0.015), lower hemoglobin (p = 0.037), older age (p = 0.047) and abnormal A5R. Conclusion We report an association between annexin A5 resistance and presence of silent infarct, low hemoglobin, and older age in a subgroup of SCA subjects. A potential role for perturbed A5R in the pathophysiology of SCA needs to be evaluated further.

Original languageEnglish (US)
Pages (from-to)53-56
Number of pages4
JournalBlood Cells, Molecules, and Diseases
Volume69
DOIs
StatePublished - Mar 2018

Keywords

  • Annexin A5 resistance
  • Antiphospholipid antibody
  • Sickle cell disease
  • Silent infarcts

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Hematology
  • Cell Biology

Fingerprint Dive into the research topics of 'Association of silent infarcts in sickle cell anemia with decreased annexin A5 resistance'. Together they form a unique fingerprint.

Cite this